Stereotactic body radiotherapy as a rescue modality for definitive treatment of therapy-refractory fistulas after pancreatic surgery - Summary - MDSpire
Advertisement
Stereotactic body radiotherapy as a rescue modality for definitive treatment of therapy-refractory fistulas after pancreatic surgery
To investigate the effectiveness of MR-guided stereotactic body radiotherapy (SBRT) as a salvage treatment for refractory postoperative pancreatic fistulas (POPF) after surgical intervention, particularly in cases where standard treatments have failed.
Key Findings:
Median drain output decreased from 47.5 ml/day to 2 ml/day (p < 0.05).
Drains were removed after a median of 44 days.
No gastrointestinal toxicity was observed; only one patient reported mild fatigue.
Rehospitalizations dropped from a median of 14 days pre-treatment to zero days post-treatment.
Interpretation:
MR-guided SBRT appears to be a non-invasive and effective option for managing refractory POPF, significantly reducing morbidity and improving patient outcomes.
Limitations:
Small sample size of only five patients, which may limit the generalizability of the findings.
Lack of long-term follow-up data.
No datasets were generated or analyzed during the study.
Conclusion:
MR-guided SBRT may serve as a safe and effective rescue therapy for persistent POPF, warranting further investigation in larger cohorts to validate these promising results.
by Meret Faranak Charlotte Iburg, Nicolaus Andratschke, Sebastian Matthias Christ, Matthias Guckenberger, Soleen Ghafoor, José Oberholzer, Henrik Petrowsky, Jan Philipp Jonas
